🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Alzheimer's Disease(AD)

Deep Cervical LymphatIc-Venous Anastomosis for Alzheimer's Disease NCT07294885NA1 site📍 Shenyang General Hospital of Shenyang Military Region · Tests: deep cervical lymphaticovenous anastomosis Daridorexant for Alzheimer Disease Prevention NCT07213349Phase 21 site📍 Montreal Douglas Mental Health University Institute · Tests: Daridorexant 50 mg, Placebo Evaluation of a Neuropsychological Tool to Assess Temporal Processing Abilities in Alzheimer's Disease NCT07341009n/a1 site📍 Caen University Hospital, Caen · Tests: Chronos battery A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD) NCT06657768Phase 113 sites📍 Los Alamitos📍 Lady Lake📍 Maitland Eli Lilly and Company · Tests: LY4006895, Placebo Digital Accessible Remote Olfactory Mediated Health Assessments for Preclinical AD NCT05881239n/a1 site📍 Boston Massachusetts General Hospital · Tests: AROMHA Brain Health Test Perturbation Training Reduces Falls in People With Alzheimer's Disease (AD) NCT05205980NA1 site📍 Valdosta Georgia State University · Tests: Perturbation training COGSCREEN II: Early Detection of Cognitive Impairment NCT07466394NA1 site📍 München Robert Perneczky · Tests: Early Detection Development of Measures to Screen for Financial Hardship in Alzheimer's Disease and Dementia NCT06922188n/a1 site📍 Seattle Fred Hutchinson Cancer Center Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers NCT05395624Phase 1, Phase 23 sites📍 San Francisco📍 Stanford📍 Jacksonville Ashvattha Therapeutics, Inc. · Tests: 18F-OP-801 Cognitive Decline in AD NCT03946930n/a1 site📍 Hong Kong Chinese University of Hong Kong NeuroCare Community Project: A Community Based Prospective Observational Study for Early Alzheimer's Detection in HK NCT07347574n/a1 site📍 Hong Kong Hong Kong University of Science and Technology · Tests: Observational Levetiracetam for Persons at Risk for Alzheimer's Disease NCT07477431Phase 22 sites📍 Toronto📍 Toronto Sunnybrook Health Sciences Centre · Tests: Levetiracetam (LEV), Placebo Multimodal Assesment of Alzheimer Patients NCT06448403n/a1 site📍 Trondheim Norwegian University of Science and Technology · Tests: MRI Scanning, 64-channel EEG, Polysomnography, Blood samples, Fecal samples [18F]-MFBG Versus [123I]-MIBG and [18F]-PE2I in PD vs. MSA and DLB vs. AD NCT06120049Phase 2, Phase 32 sites📍 Ghent📍 Leuven prof. dr. Koen Van Laere · Tests: [18F]-MFBG PET CT, [18F]-FE-PE2I PET CT or PET MRI, [123I]-MIBG SPECT CT, [18F]-MFBG PET dosimetry scans Longitudinal Profiling of Plasma-Derived Glial Extracellular Vesicles in Alzheimer's Disease NCT07803055NA1 site📍 Rome Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Tests: blood sampling Music Therapy for Patients With Alzheimer's Disease NCT05151562NA1 site📍 Baltimore Johns Hopkins University · Tests: Virtual Music Therapy Mindfulness to Enhance Cognitive Health in Latino Older Adults NCT07040904NA1 site📍 St Louis Washington University School of Medicine · Tests: mindfulness Cognitive Vulnerability to Stress in Individuals at Risk for Alzheimer's Disease NCT05795634NA1 site📍 Baltimore Johns Hopkins University · Tests: Trier Social Stress Test Interleukine-2 (IL-2) Plus Semaglutide in Alzheimer's Disease NCT07651319Phase 1, Phase 21 site📍 Houston The Methodist Hospital Research Institute · Tests: IL-2 (Aldesleukin), Semaglutide Plus IL-2, Placebo Brain NAD in Alzheimer's Disease NCT07127510n/a1 site📍 Boca Raton Florida Atlantic University A Study of AMDX-2011P in Participants With Alzheimer's Disease NCT06514001Phase 21 site📍 Phoenix Amydis Inc. · Tests: AMDX-2011P A Phase I Study of [18F]Flortaucipir PET Imaging in Chinese Subjects: Safety, Pharmacokinetics, Biodistribution, Radiation Dosimetry, and Preliminary Diagnostic Efficacy NCT07580703Phase 11 site📍 Beijing Eli Radiopharma · Tests: [18F]Flortaucipir Injection A Study to Evaluate the Efficacy and Safety of TTYP01 Tablets in Early Symptomatic Alzheimer's Disease NCT07252440Phase 21 site📍 Chongqing Shanghai Auzone Biological Technology Co., Ltd. · Tests: TTYP01 tables 60mg, TTYP01 tables 90mg, TTYP01 tables 0mg Deep Cervical Lymphatic Venous Anastomosis in the Treatment of Alzheimer's Disease (CLEAN-AD) NCT07073066NA9 sites📍 Dongguan📍 Guangdong📍 Zhengzhou Beijing Tiantan Hospital · Tests: DC-LVA treatment plus usual care, Usual care Repurposing Siponimod for Alzheimer's Disease NCT06639282Phase 21 site📍 Phoenix St. Joseph's Hospital and Medical Center, Phoenix · Tests: Siponimod, Placebo Quantification of Hsp90 in the Human Brain NCT07380204NA1 site📍 Leuven Universitaire Ziekenhuizen KU Leuven · Tests: [11C]HSP990 PET dosimetry, [11C]HSP990 PET test-retest, [11C]HSP990 simplified scan protocol Cognitive Health in Ageing Register: Investigational and Observational Trial Studies in Dementia Research (CHARIOT): Prospective Readiness Cohort (PRO) Longitudinal Study NCT06953167n/a1 site📍 London Imperial College London VR Pupillometry in Cognitive Impairment NCT07402356n/a1 site📍 München Max-Planck-Institute of Psychiatry Transcranial Photobiomodulation (tPBM) in Alzheimer's Disease Study NCT07224607NA1 site📍 Los Angeles Cedars-Sinai Medical Center · Tests: Photobiomodulation A Phase 1 Clinical Trial to Investigate the Safety, Tolerability, and Pharmacokinetics of AS-S603 in Healthy Participants NCT06786676Phase 11 site📍 Seoul Amyloid Solution Inc · Tests: AS-S603, Placebo
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy